1-3 of 3
Nahal Masrour
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT129: HyPeR: A phase 1, dose escalation and expansion trial of guadecitabine (SGI-110), a second-generation hypomethylating agent in combination with pembrolizumab (MK3475) in patients with refractory solid tumors

Dionysis Papadatos-Pastos, Abhijit Pal, Melek Akay, Malaka Ameratunga, Sanjena Mithra, Joo-Ern Ang, Sofia Levva, Reece Caldwell, Ruth Riisnaes, Mateus Crespo, Wei Yuan, George Seed, Bora Gurel, Ines Figueiredo, Rita Pereira, Susana Miranda, Anna Ferreira, Suzanne Carreira, Claudia Bertan, Chloe Baker, Ricardo Morilla, Robert Brown, Nahal Masrour, Toby Prout, Anna Zachariou, Alison Turner, Mona Parmar, Mark Van de Velde, Ben Jenkins, Christina Yap, Nina Tunariu, Udai Banerji, Juanita Lopez, Anna Minchom, Johann De Bono
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT129.
https://doi.org/10.1158/1538-7445.AM2020-CT129
Published: 15 August 2020
View article titled, Abstract CT129: HyPeR: A phase 1, dose escalation and expansion trial of guadecitabine (SGI-110), a second-generation hypomethylating agent in combination with pembrolizumab (MK3475) in patients with refractory solid tumors
Journal Articles

Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis

Edward Curry, Constanze Zeller, Nahal Masrour, Darren K. Patten, John Gallon, Charlotte S. Wilhelm-Benartzi, Sadaf Ghaem-Maghami, David D. Bowtell, Robert Brown
Journal: Cancer Research
Cancer Res (2018) 78 (6): 1383–1391.
https://doi.org/10.1158/0008-5472.CAN-17-1650
Published: 14 March 2018
View article titled, Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis
Open the PDF for Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis in another window
Includes: Supplementary data
Journal Articles

Abstract 4088: Cotreatment with decitabine and paclitaxel is affected by the re-expression of drug-metabolising enzymes

Laura Cosentino, Nahal Masrour, Julie Burns, Weishuo Fang, Robert Brown, Phil Burns, Klaus Pors
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4088.
https://doi.org/10.1158/1538-7445.AM2012-4088
Published: 15 April 2012
View article titled, Abstract 4088: Cotreatment with decitabine and paclitaxel is affected by the re-expression of drug-metabolising enzymes